MedTrace Logo

Telerehabilitation for Diastasis Recti

NCT07017309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2025-06-12

No results posted yet for this study

Summary

This is a pilot study exploring how a 12-week telerehabilitation program can help new mothers manage diastasis recti abdominis (DRA)-a common trunk dysfunction which causes abdominal muscle separation after childbirth. Instead of needing to attend in-person sessions, participants are encouraged to join guided exercise sessions online, with real-time supervision from a physiotherapist. The study aims to assess participant satisfaction with the remote program using a standardized questionnaire. It also evaluates potential changes in abdominal muscle separation (diastasis) through ultrasound, improvements in trunk muscle endurance using functional tests, and changes in body image perception using a body image questionnaire.

Conditions

  • Diastasis Recti
  • Telerehabilitation
  • Diastasis Recti Abdominis (DRA)
  • Diastasis Recti And Weakness Of The Linea Alba

Interventions

BEHAVIORAL

Telerehabilitation Protocol for Diastasis Recti

12-week telerehabilitation program combining synchronous (live, supervised by physiotherapists) and asynchronous (video -recorded) therapeutic exercise sessions focused on progressive inner core exercises (i.e. transversus abdominis, pelvic floor muscle retraining), outer core strengthening, and functional retraining.

Sponsors & Collaborators

  • University of Patras

    lead OTHER

Principal Investigators

  • Evdokia Billis, PhD · University of Patras

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2025-05-20
Completion
2025-05-20

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07017309 on ClinicalTrials.gov